Conference abstract
Research articlePublished 30 Nov 2020
Non-linear Mixed Effects Modeling and Simulation for Exploring Variability Sources in Dissolution Curves: A BCS Class II Case Example
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: Irbesartan is a BCS class II compound that exhibits pH– and buffer capacity–dependent dissolution behavior. The aim of this study was to apply non-linear mixed effects modelling on dissolution data of two immediate release products containing Irbesartan in order to characterize and quantify the sources of inter-dissolution profile variability. Methods: Nonlinear mixed effects modelling was applied to describe the dissolution curves obtained for Irbesartan in three different pH-value media (1.2, 4.5, 6.8) with two different products (reference product: Aprovel® and a generic test product). Simulations performed and the impact of inter-dissolution variability was assessed. Results: The % Irbesartan dissolved to time was found to follow a Weibull distribution. Τhe population scale parameter was estimated 0.252 and the shape parameter was estimated 0.706. The pH-value of the dissolution medium was found to significantly affect the scale parameter, while the formulation was found to affect the shape parameter. Simulations showed that probably some discrepancies in the in vivo performance of the two products can be expected. Conclusion: Through this case study the applicability and usefulness of nonlinear mixed effects modelling in oral drug formulation was highlighted and resides in its ability to identify and quantify sources of variability.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 27 Oct 2014
Dissolution testing of nicotinamide cocrystals of a model BCS-Class-II drug
Research article · 30 Jul 2018
Formulation and Development Studies on Enhancement of Dissolution Rate of BCS Class II Antidiabetic Drug
Research article · 2013
Dissolution Effect of Gastric and Intestinal pH fora BCS class II drug, Pioglitazone: New in vitro Dissolution System to Predict in vivo Dissolution
Opinion · 29 May 2024
Role of Solid Dispersions in Enhancing Bioavailability of BCS Class II Drugs
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Eleni Karatza”
- BylineArticles whose byline prints “Vangelis Karalis”
